Vor Biopharma Inc at Credit Suisse Healthcare Conference Transcript
Hello. My name is Robert Ang. I am privileged to be CEO and President of Vor Bio. Vor is a biotechnology company focused on trying to cure blood cancers through cell and genome engineering. I will point you to our disclaimer slide, which you can read on our website at your leisure.
So what we're trying to do in Vor is we are trying to revolutionize blood cancers by changing the way patients are receiving transplants. And so in many different kinds of blood cancers, the standard of care was actually invented around 50 years ago.
With transplantation, you could take cells from the same patient or an allogeneic donor -- the stranger who is matched to the patient -- and actually transplant those cells permanently into the patient to replace the bone marrow. And so that was really a revolution in its time where it wasn't possible -- thought to be possible previously, and can provide really lasting clinical benefits for patients, even some cures.
Unfortunately, in the majority of people who are transplanted, the cancer returns. And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
